MedTrace Logo

Validation of Serum Metabolite Differences in Patients With Gallstones and Gallbladder Cancer

NCT07744477 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 230

Last updated 2026-08-04

No results posted yet for this study

Summary

We have observed that the serum levels of certain metabolites differ between Chilean patients with gallbladder cancer and those with gallstone disease. Based on these discovery results, we selected ten candidate metabolites based on the smallest p-values among metabolites exhibiting a fold-change greater than 1.5. The aim of the present study is to validate these ten differential metabolite levels in an independent cohort of Chilean patients with gallbladder cancer and gallstone disease, and to assess the transferability of these findings to other patient populations.

Conditions

  • Gallstone Disease
  • Gallbladder Malignant Neoplasm

Interventions

OTHER

serum samples

serum samples

Sponsors & Collaborators

  • Centre Paul Strauss

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • Bolivia
  • Chile
  • Germany
  • Peru

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07744477 on ClinicalTrials.gov